Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic

  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Selecta Biosciences (NQ: SELB )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 13, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Selecta Biosciences

< Previous 1 2 3 4 Next >
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO 
Via Benzinga
56 Biggest Movers From Friday
Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on... 
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
Why Selecta Biosciences' Stock Is Trading Higher Today
Selecta Biosciences (NASDAQ:SELB) shares are tra... 
Via Benzinga
48 Stocks Moving In Friday's Mid-Day Session
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 68.43% to $17.18 during Friday's pre-market session. The market value of their outstanding shares is at $119.6... 
Via Benzinga
Selecta's Gene Therapy Trial For Genetic Metabolic Disorder Put On FDA Hold
The FDA has placed a clinical hold on Selecta Biosciences Inc's (NASDAQ: SELB) Phase 1/2 trial of SEL-302 (which consists of MMA-101 plus ImmTOR) for... 
Via Benzinga
Exposures Product Safety
25 Stocks Moving in Friday's Pre-Market Session
Gainers iSpecimen Inc. (NASDAQ: ISPC) rose 56.9% to $16.00 in pre-market trading. The company recently announced it has been contracted to support new advanced research on COVID-... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Tumble Amid COVID-19 Jitters
Pre-open movers U.S. stock futures traded lower in early pre-market trade after a new COVID-19 variant was detected in South Africa. Investors are awaiting earnings results from... 
Via Benzinga
Exposures COVID-19
5 Stocks To Watch For November 26, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Pinduoduo Inc. (NASDAQ: PDD) to report quarterly earnings at $0.02 per share on revenue of $4.16... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers XTL Biopharmaceuticals (NASDAQ:XTLB 
Via Benzinga
Selecta Biosciences's Return On Capital Employed Insights
Benzinga Pro data, Selecta Biosciences (NASDAQ:SELB) reported Q3 sales of $24.43 million. Earnings fell to a loss of $1.97 million, resulting in a 535.62% decrease from last... 
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
Selecta Biosciences Posts Encouraging Data For ImmTOR Platform
Selecta Biosciences Inc (NASDAQ: SELB) announced top-line results from the Phase 1 study evaluating the ImmTOR platform to mitigate the formation of neutralizing... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Ocugen (NASDAQ:OCGN) stock increased by 31.15% to $12.25 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.4 billion.... 
Via Benzinga
Selecta In-Licenses Rights To IgG Protease Platform
Selecta Biosciences Inc (NASDAQ: SELB) has announced a strategic licensing agreement to advance a next-generation IgG protease. The partnership leverages... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers OpGen (NASDAQ:OPGN) shares moved upwards by 30.07% to $3.59 during Monday's pre-market session. The market value of their outstanding shares is at $137.3... 
Via Benzinga
Selecta Biosciences: Q2 Earnings Insights
Shares of Selecta Biosciences (NASDAQ:SELB) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were up 100.00% over the past year to... 
Via Benzinga
77 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers RAPT Therapeutics (NASDAQ:RAPT) s... 
Via Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS... 
Via Benzinga
61 Biggest Movers From Yesterday
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company announced new results from its TATX-03 PolyTope Therapy... 
Via Benzinga
Notable Insider Buys Of The Last Week: Bumble, Coty, Peloton Interactive, And More
Some return buyers were among the insiders acquiring shares this last week. A beauty products company and an online dating outfit were among the firms that saw notable insider buying. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an... 
Via Benzinga
Notable Insider Buys Of The Last Week: Bumble, Coty, Peloton Interactive, More
Insider buying can be an encouraging signal for potential investors, especially when markets are uncertain or near all-time highs. Some return buyers were among the insiders... 
Via Benzinga
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)... 
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Owens & Minor (NYSE:OMI) shares rose 25.47% to $40.66 during Wednesday's regular session. As of 12:31 EST, this security is trading at a volume of 5.4... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday. Flywire Corporation (NASDAQ: FLYW) gained 46.3% to settle at $35.10 after the company priced... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.